FindTrial
Sign In

Oral hypoglycaemic activity of Pleurotus mushrooms on diabetic subjects

Oral hypoglycaemic and anti-inflammatory activity of P.ostreatus and P.cystidiosus on diabetic subjects, who are on diet control

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
SLCTR
Registry ID
SLCTR/2013/021
Enrollment
Unknown
Registered
2013-06-24
Start date
2013-07-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus

Interventions

All patients who present to the Family Practice Centre, Faculty of Medical Sciences, University of Sri Jayewardenepura within the inclusion criteria will be considered for the study. Consenting patie

Sponsors

University of Sri Jayewardenepura
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Type 2 diabetic patients 2. On diet control only 3. Ability to read and understand Sinhala and English

Exclusion criteria

Exclusion criteria: 1. Type 1 diabetics 2. Pregnancy /breastfeeding 3. Patients on any oral hypoglycaemic medication 4. Patients on insulin 5. Patients on herbal medications known to have an effect on blood glucose

Design outcomes

Primary

MeasureTime frame
Fasting blood glucose [Prior to administration of the mushroom suspension ] Post glucose loaded (OGTT) blood glucose [2 hours after glucose load.] Serum insulin levels (using ELIZA kits) [2 hours after glucose load.]—

Secondary

MeasureTime frame
Change in liver function : serum alanine amino transferase, aspartate amino transferase, alkaline phosphatase, gamma glutamyl transpeptidase [At base line and at the end of 4 weeks ] Change in renal function : serum creatinine [At baseline and at the end of 4 weeks]—

Countries

Sri Lanka

Contacts

Public ContactDr. Sugandhika Suresh

Senior Lecturer

Outcome results

None listed

Source: SLCTR (via WHO ICTRP) · Data processed: Aug 9, 2026